Invention Grant
- Patent Title: Thioether triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidase
-
Application No.: US16145345Application Date: 2018-09-28
-
Publication No.: US10981879B2Publication Date: 2021-04-20
- Inventor: Andrew Quoc Viet , Nicholas R. Wurtz
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen; Shrikant Kulkarni
- Main IPC: C07D249/18
- IPC: C07D249/18 ; C07D249/16 ; C07D471/04 ; C07D487/04 ; A61K31/437 ; A61K31/7064
Abstract:
The present invention provides compounds of Formula (I): wherein A, X and Y are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.
Public/Granted literature
- US20190031623A1 THIOETHER TRIAZOLOPYRIDINE AND TRIAZOLOPYRIMIDINE INHIBITORS OF MYELOPEROXIDASE Public/Granted day:2019-01-31
Information query
